{"transactions":[{"id":1425957,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-22T09:06:37.000Z","date":"2024-08-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":39134,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were disposed of pursuant to the terms of an Agreement and Plan of Merger (the \"Merger Agreement\")dated as of June 6, 2024, by and among Asensus Surgical, Inc., a Delaware corporation (\"Asensus\"), KARL STORZ Endoscopy-America, Inc., a California corporation (\"Parent\"), and Karl Storz California Inc., a California corporation (\"Merger Sub\"), pursuant to which Merger Sub merged with and into Asensus with Asensus as the surviving corporation of the merger (the \"Merger\").  Upon the effective time of the Merger, the reporting person received $0.35 in cash, without interest and less applicable withholding taxes for each share of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-24-027540","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876378/000143774924027540/rdgdoc.xml","form_type":"4"}},{"id":1425956,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-22T09:06:37.000Z","date":"2024-08-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were disposed of pursuant to the terms of an Agreement and Plan of Merger (the \"Merger Agreement\")dated as of June 6, 2024, by and among Asensus Surgical, Inc., a Delaware corporation (\"Asensus\"), KARL STORZ Endoscopy-America, Inc., a California corporation (\"Parent\"), and Karl Storz California Inc., a California corporation (\"Merger Sub\"), pursuant to which Merger Sub merged with and into Asensus with Asensus as the surviving corporation of the merger (the \"Merger\").  Upon the effective time of the Merger, the reporting person received $0.35 in cash, without interest and less applicable withholding taxes for each share of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-24-027540","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000143774924027540/rdgdoc.xml","form_type":"4"}},{"id":1708135,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T18:26:08.000Z","date":"2023-12-14","kind":"sale","planned":false,"acquired":false,"shares":18134,"price":0.28,"value":5077.52,"ownership":{"direct":false,"nature":"By Synecor LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Synecor LLC, the registered owner of the shares, is dissolving effective December 31, 2023.  William Starling, the trustee of the Buyer, is the CEO of Synecor LLC and is an independent director of Asensus Surgical, Inc.  A trust of which William Starling is a trustee and settlor bought the shares of Asensus Surgical, Inc. from Synecor LLC for the closing price on the date of purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Synecor LLC, the registered owner of the shares, is dissolving effective December 31, 2023.  William Starling, the trustee of the Buyer, is the CEO of Synecor LLC and is an independent director of Asensus Surgical, Inc.  A trust of which William Starling is a trustee and settlor bought the shares of Asensus Surgical, Inc. from Synecor LLC for the closing price on the date of purchase."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-059023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919123059023/doc4.xml","form_type":"4"}},{"id":1708134,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T18:26:08.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":18134,"price":0.28,"value":5077.52,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Synecor LLC, the registered owner of the shares, is dissolving effective December 31, 2023.  William Starling, the trustee of the Buyer, is the CEO of Synecor LLC and is an independent director of Asensus Surgical, Inc.  A trust of which William Starling is a trustee and settlor bought the shares of Asensus Surgical, Inc. from Synecor LLC for the closing price on the date of purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Synecor LLC, the registered owner of the shares, is dissolving effective December 31, 2023.  William Starling, the trustee of the Buyer, is the CEO of Synecor LLC and is an independent director of Asensus Surgical, Inc.  A trust of which William Starling is a trustee and settlor bought the shares of Asensus Surgical, Inc. from Synecor LLC for the closing price on the date of purchase."}],"balance_after":39134,"source":{"system":"sec-edgar","filing":"0001209191-23-059023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919123059023/doc4.xml","form_type":"4"}},{"id":1863048,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-08T17:03:40.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":55748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest on a quarterly basis over the one year following the date of grant, with the first vesting on the date of grant."}],"balance_after":55748,"derivative":{"exercise_price":0.56,"expiration_date":"2030-06-06","underlying":"Common Stock","underlying_shares":55748},"source":{"system":"sec-edgar","filing":"0001209191-23-035495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919123035495/doc4.xml","form_type":"4"}},{"id":2231931,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-15T19:36:49.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":55340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock options will vest on a quarterly basis over the one year following the date of grant, with the first vesting on the date of grant."}],"balance_after":55340,"derivative":{"exercise_price":0.38,"expiration_date":"2029-06-14","underlying":"Common Stock","underlying_shares":55340},"source":{"system":"sec-edgar","filing":"0001209191-22-037126","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919122037126/doc4.xml","form_type":"4"}},{"id":2231930,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-15T19:36:49.000Z","date":"2022-06-13","kind":"sale","acquired":false,"shares":27010,"price":0.4,"value":10804.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $0.4094 to $0.39, with a weighted average price per share of $0.40.  The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":13846,"source":{"system":"sec-edgar","filing":"0001209191-22-037126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919122037126/doc4.xml","form_type":"4"}},{"id":2646225,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-07-02T19:13:10.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":4310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan in lieu of an annual cash retainer, paid quarterly in arrears for the quarter ended June 30, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The award is fully exercisable six months after the grant date, subject to earlier acceleration as approved by the Board of Directors."}],"balance_after":4310,"derivative":{"exercise_price":3.17,"exercise_date":"2021-12-31","expiration_date":"2028-06-30","underlying":"Common Stock","underlying_shares":4310},"source":{"system":"sec-edgar","filing":"0001209191-21-045186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919121045186/doc4.xml","form_type":"4"}},{"id":2646224,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T19:13:10.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":13846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of the Registrant's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Forfeiture restrictions will lapse on the RSUs on the first anniversary of the date of grant, provided that if the date of the 2022 annual meeting of stockholders is earlier, the restrictions will lapse on the date of the annual meeting."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of the Registrant's common stock."}],"balance_after":40856,"source":{"system":"sec-edgar","filing":"0001209191-21-045186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919121045186/doc4.xml","form_type":"4"}},{"id":2762653,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-04-02T18:13:01.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":3628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan in lieu of an annual cash retainer, paid quarterly in arrears for the quarter ended March 31, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award is fully exercisable six months after the grant date, subject to earlier acceleration as approved by the Board of Directors."}],"balance_after":3628,"derivative":{"exercise_price":3.25,"exercise_date":"2021-10-01","expiration_date":"2028-03-31","underlying":"Common Stock","underlying_shares":3628},"source":{"system":"sec-edgar","filing":"0001209191-21-024775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919121024775/doc4.xml","form_type":"4"}},{"id":2923362,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-01-05T19:12:21.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":14756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan in lieu of an annual cash retainer, paid quarterly in arrears for the quarter ended December 31, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award is fully exercisable six months after the grant date, subject to earlier acceleration as approved by the Board of Directors."}],"balance_after":14756,"derivative":{"exercise_price":0.63,"exercise_date":"2021-07-01","expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":14756},"source":{"system":"sec-edgar","filing":"0001209191-21-001612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919121001612/doc4.xml","form_type":"4"}},{"id":3017363,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-10-02T17:42:09.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":14852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan in lieu of an annual cash retainer, paid quarterly in arrears for the quarter ended September 30, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award is fully exercisable six months after the grant date, subject to earlier acceleration as approved by the Board of Directors."}],"balance_after":14852,"derivative":{"exercise_price":0.35,"exercise_date":"2021-03-30","expiration_date":"2027-09-30","underlying":"Common Stock","underlying_shares":14852},"source":{"system":"sec-edgar","filing":"0001209191-20-053300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919120053300/doc4.xml","form_type":"4"}},{"id":3115382,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-06-10T20:05:38.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock options will vest 25% on each of September 8, 2020, December 8, 2020, March 8, 2021 and June 8, 2021, provided that if the date of the 2021 annual meeting of stockholders is earlier, the last vesting occurs on the date of the annual meeting. Subject to acceleration of vesting in full upon consummation of a change in control of the Registrant."}],"balance_after":31250,"derivative":{"exercise_price":0.82,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001209191-20-035705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919120035705/doc4.xml","form_type":"4"}},{"id":3115381,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T20:05:38.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the Reporting Person remains in continuous service during the vesting period."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock."}],"balance_after":27010,"source":{"system":"sec-edgar","filing":"0001209191-20-035705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919120035705/doc4.xml","form_type":"4"}},{"id":3115380,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T20:05:38.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":4510,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the Reporting Person remains in continuous service during the vesting period."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock."}],"balance_after":4510,"source":{"system":"sec-edgar","filing":"0001209191-20-035705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919120035705/doc4.xml","form_type":"4"}},{"id":3176003,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-16T21:23:33.000Z","date":"2020-04-13","kind":"other","acquired":true,"shares":9313,"price":0.3997,"value":3722.4061,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects a liquidation distribution to the W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990 (the \"Family Trust\") of shares of common stock by Synergy Life Science Partners, L.P., a dissolving limited partnership.  The reporting person is a trustee of the Family Trust and was a managing director of the dissolving limited partnership."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a liquidation distribution to the W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990 (the \"Family Trust\") of shares of common stock by Synergy Life Science Partners, L.P., a dissolving limited partnership.  The reporting person is a trustee of the Family Trust and was a managing director of the dissolving limited partnership."}],"balance_after":21281,"source":{"system":"sec-edgar","filing":"0001209191-20-024698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919120024698/doc4.xml","form_type":"4"}},{"id":3176002,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-16T21:23:33.000Z","date":"2020-04-13","kind":"other","acquired":false,"shares":131102,"price":0.3997,"value":52401.4694,"ownership":{"direct":false,"nature":"By L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of all shares in liquidation by Synergy Life Science Partners L.P. The reporting person was a managing director of Synergy Life Science Partners L.P."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Distribution of all shares in liquidation by Synergy Life Science Partners L.P. The reporting person was a managing director of Synergy Life Science Partners L.P."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-024698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919120024698/doc4.xml","form_type":"4"}},{"id":3334539,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T19:44:53.000Z","date":"2019-12-19","kind":"sale","acquired":false,"shares":6015,"price":1.44,"value":8661.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock sold by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.44 to $1.445 inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a reverse stock split of the Registrant's common stock at a ratio of one-for-thirteen with marketplace effectiveness on December 12, 2019 whereby the resulting fractional share was rounded up to the nearest whole share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares of Common Stock sold by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990."}],"balance_after":11968,"source":{"system":"sec-edgar","filing":"0001209191-19-061657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919119061657/doc4.xml","form_type":"4"}},{"id":3334538,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T19:44:53.000Z","date":"2019-12-19","kind":"sale","acquired":false,"shares":3587,"price":1.39,"value":4985.93,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock sold by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a reverse stock split of the Registrant's common stock at a ratio of one-for-thirteen with marketplace effectiveness on December 12, 2019 whereby the resulting fractional share was rounded up to the nearest whole share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares of Common Stock sold by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990."}],"balance_after":17983,"source":{"system":"sec-edgar","filing":"0001209191-19-061657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919119061657/doc4.xml","form_type":"4"}},{"id":3548149,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Award","published_at":"2019-04-26T20:09:08.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":29104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The vesting schedule is 25% of the stock option award on July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020.  Subject to acceleration of vesting in full upon consummation of a change in control of the registrant."}],"balance_after":29104,"derivative":{"exercise_price":1.96,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":29104},"source":{"system":"sec-edgar","filing":"0001209191-19-026322","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919119026322/doc4.xml","form_type":"4"}},{"id":3548148,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T20:09:08.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":20380,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the reporting person remains in continuous service during the vesting period."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock."}],"balance_after":20380,"source":{"system":"sec-edgar","filing":"0001209191-19-026322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919119026322/doc4.xml","form_type":"4"}},{"id":3806878,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-27T20:01:57.000Z","date":"2018-09-27","kind":"sale","acquired":false,"shares":1139649,"price":6.13,"value":6986048.37,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Synergy Life Science Partners, L.P., the holder of these shares, sold an aggregate of 1,700,000 shares of TransEnterix stock on September 25, 2018, an aggregate of 775,000 shares on September 26, 2018, and an aggregate of 1,139,649 shares on September 27, 2018. The reporting person is a control person of the General Partner of Synergy Life Science Partners, L.P.  The reporting person disclaims any beneficial ownership of the shares of TransEnterix stock owned by Synergy Life Science Partners, L.P. and has no pecuniary interest in such shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in Column 4 is a weighted average price. These shares were sold by Synergy Life Science Partners, L.P. in multiple transactions at prices ranging from $6.05 to $6.205 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Synergy Life Science Partners, L.P., the holder of these shares, sold an aggregate of 1,700,000 shares of TransEnterix stock on September 25, 2018, an aggregate of 775,000 shares on September 26, 2018, and an aggregate of 1,139,649 shares on September 27, 2018. The reporting person is a control person of the General Partner of Synergy Life Science Partners, L.P.  The reporting person disclaims any beneficial ownership of the shares of TransEnterix stock owned by Synergy Life Science Partners, L.P. and has no pecuniary interest in such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Synergy Life Science Partners, L.P., the holder of these shares, sold an aggregate of 1,700,000 shares of TransEnterix stock on September 25, 2018, an aggregate of 775,000 shares on September 26, 2018, and an aggregate of 1,139,649 shares on September 27, 2018. The reporting person is a control person of the General Partner of Synergy Life Science Partners, L.P.  The reporting person disclaims any beneficial ownership of the shares of TransEnterix stock owned by Synergy Life Science Partners, L.P. and has no pecuniary interest in such shares."}],"balance_after":1704320,"source":{"system":"sec-edgar","filing":"0001209191-18-052512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118052512/doc4.xml","form_type":"4"}},{"id":3806877,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-27T20:01:57.000Z","date":"2018-09-26","kind":"sale","acquired":false,"shares":775000,"price":6.26,"value":4851500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Synergy Life Science Partners, L.P., the holder of these shares, sold an aggregate of 1,700,000 shares of TransEnterix stock on September 25, 2018, an aggregate of 775,000 shares on September 26, 2018, and an aggregate of 1,139,649 shares on September 27, 2018. The reporting person is a control person of the General Partner of Synergy Life Science Partners, L.P.  The reporting person disclaims any beneficial ownership of the shares of TransEnterix stock owned by Synergy Life Science Partners, L.P. and has no pecuniary interest in such shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price reported in Column 4 is a weighted average price. These shares were sold by Synergy Life Science Partners, L.P. in multiple transactions at prices ranging from $6.20 to $6.475 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Synergy Life Science Partners, L.P., the holder of these shares, sold an aggregate of 1,700,000 shares of TransEnterix stock on September 25, 2018, an aggregate of 775,000 shares on September 26, 2018, and an aggregate of 1,139,649 shares on September 27, 2018. The reporting person is a control person of the General Partner of Synergy Life Science Partners, L.P.  The reporting person disclaims any beneficial ownership of the shares of TransEnterix stock owned by Synergy Life Science Partners, L.P. and has no pecuniary interest in such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Synergy Life Science Partners, L.P., the holder of these shares, sold an aggregate of 1,700,000 shares of TransEnterix stock on September 25, 2018, an aggregate of 775,000 shares on September 26, 2018, and an aggregate of 1,139,649 shares on September 27, 2018. The reporting person is a control person of the General Partner of Synergy Life Science Partners, L.P.  The reporting person disclaims any beneficial ownership of the shares of TransEnterix stock owned by Synergy Life Science Partners, L.P. and has no pecuniary interest in such shares."}],"balance_after":2843969,"source":{"system":"sec-edgar","filing":"0001209191-18-052512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118052512/doc4.xml","form_type":"4"}},{"id":3806876,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-27T20:01:57.000Z","date":"2018-09-25","kind":"sale","acquired":false,"shares":1700000,"price":6.4,"value":10880000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Synergy Life Science Partners, L.P., the holder of these shares, sold an aggregate of 1,700,000 shares of TransEnterix stock on September 25, 2018, an aggregate of 775,000 shares on September 26, 2018, and an aggregate of 1,139,649 shares on September 27, 2018. The reporting person is a control person of the General Partner of Synergy Life Science Partners, L.P.  The reporting person disclaims any beneficial ownership of the shares of TransEnterix stock owned by Synergy Life Science Partners, L.P. and has no pecuniary interest in such shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in Column 4 is a weighted average price. These shares were sold by Synergy Life Science Partners, L.P. in multiple transactions at prices ranging from $6.25 to $6.90 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Synergy Life Science Partners, L.P., the holder of these shares, sold an aggregate of 1,700,000 shares of TransEnterix stock on September 25, 2018, an aggregate of 775,000 shares on September 26, 2018, and an aggregate of 1,139,649 shares on September 27, 2018. The reporting person is a control person of the General Partner of Synergy Life Science Partners, L.P.  The reporting person disclaims any beneficial ownership of the shares of TransEnterix stock owned by Synergy Life Science Partners, L.P. and has no pecuniary interest in such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Synergy Life Science Partners, L.P., the holder of these shares, sold an aggregate of 1,700,000 shares of TransEnterix stock on September 25, 2018, an aggregate of 775,000 shares on September 26, 2018, and an aggregate of 1,139,649 shares on September 27, 2018. The reporting person is a control person of the General Partner of Synergy Life Science Partners, L.P.  The reporting person disclaims any beneficial ownership of the shares of TransEnterix stock owned by Synergy Life Science Partners, L.P. and has no pecuniary interest in such shares."}],"balance_after":3618969,"source":{"system":"sec-edgar","filing":"0001209191-18-052512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118052512/doc4.xml","form_type":"4"}},{"id":3816310,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T19:40:24.000Z","date":"2018-09-13","kind":"other","acquired":true,"shares":78192,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Synecor, LLC distributed an aggregate of 156,384 shares of TransEnterix stock to its officers in satisfaction of guaranteed payments.  The reporting person is the chief executive officer of Synecor, LLC. The reporting person received 78,192 of such shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Synecor, LLC distributed an aggregate of 156,384 shares of TransEnterix stock to its officers in satisfaction of guaranteed payments.  The reporting person is the chief executive officer of Synecor, LLC. The reporting person received 78,192 of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares of Common Stock held by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares of Common Stock held by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990."}],"balance_after":213415,"source":{"system":"sec-edgar","filing":"0001209191-18-051149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118051149/doc4.xml","form_type":"4"}},{"id":3816309,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T19:40:24.000Z","date":"2018-09-13","kind":"other","acquired":false,"shares":156384,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Synecor, LLC distributed an aggregate of 156,384 shares of TransEnterix stock to its officers in satisfaction of guaranteed payments.  The reporting person is the chief executive officer of Synecor, LLC. The reporting person received 78,192 of such shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Synecor, LLC distributed an aggregate of 156,384 shares of TransEnterix stock to its officers in satisfaction of guaranteed payments.  The reporting person is the chief executive officer of Synecor, LLC. The reporting person received 78,192 of such shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Synecor, LLC distributed an aggregate of 156,384 shares of TransEnterix stock to its officers in satisfaction of guaranteed payments.  The reporting person is the chief executive officer of Synecor, LLC. The reporting person received 78,192 of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Synecor, LLC distributed an aggregate of 156,384 shares of TransEnterix stock to its officers in satisfaction of guaranteed payments.  The reporting person is the chief executive officer of Synecor, LLC. The reporting person received 78,192 of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Synecor, LLC distributed an aggregate of 156,384 shares of TransEnterix stock to its officers in satisfaction of guaranteed payments.  The reporting person is the chief executive officer of Synecor, LLC. The reporting person received 78,192 of such shares."}],"balance_after":235738,"source":{"system":"sec-edgar","filing":"0001209191-18-051149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118051149/doc4.xml","form_type":"4"}},{"id":3860338,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-07-27T09:00:38.000Z","date":"2018-07-25","kind":"exercise","acquired":false,"shares":21625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Previously vested."}],"balance_after":0,"derivative":{"exercise_price":0.35,"expiration_date":"2022-04-12","underlying":"Common Stock","underlying_shares":21625},"source":{"system":"sec-edgar","filing":"0001209191-18-044132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118044132/doc4.xml","form_type":"4"}},{"id":3860337,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-07-27T09:00:38.000Z","date":"2018-07-25","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Previously vested."}],"balance_after":0,"derivative":{"exercise_price":0.48,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-044132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118044132/doc4.xml","form_type":"4"}},{"id":3860336,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-27T09:00:38.000Z","date":"2018-07-25","kind":"exercise","acquired":true,"shares":21625,"price":0.35,"value":7568.75,"ownership":{"direct":true},"balance_after":66987,"source":{"system":"sec-edgar","filing":"0001209191-18-044132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118044132/doc4.xml","form_type":"4"}},{"id":3860335,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-27T09:00:38.000Z","date":"2018-07-25","kind":"exercise","acquired":true,"shares":25000,"price":0.48,"value":12000.0,"ownership":{"direct":true},"balance_after":45362,"source":{"system":"sec-edgar","filing":"0001209191-18-044132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118044132/doc4.xml","form_type":"4"}},{"id":3916217,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Award","published_at":"2018-05-29T07:08:07.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":35592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The vesting schedule is 25% of the stock option award on each of July 1, 2018, October 1, 2018, January 1, 2019 and April 1, 2019."}],"balance_after":35592,"derivative":{"exercise_price":3.17,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":35592},"source":{"system":"sec-edgar","filing":"0001209191-18-033661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118033661/doc4.xml","form_type":"4"}},{"id":3916216,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T07:08:07.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":20362,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units.  Each restricted stock unit represents the right to receive one share of the Registrant's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units.  Each restricted stock unit represents the right to receive one share of the Registrant's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the reporting person remains in continuous service during the vesting period."}],"balance_after":20362,"source":{"system":"sec-edgar","filing":"0001209191-18-033661","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919118033661/doc4.xml","form_type":"4"}},{"id":3941063,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":3,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2018-05-10T01:22:42.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":3102190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mudit K. Jain, a director of the Issuer, and each of Messrs. Stack and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Such persons and entities disclaim beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":466494},"source":{"system":"sec-edgar","filing":"0001104659-18-031870","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031870/a4.xml","form_type":"4"}},{"id":3941062,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":3,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2018-05-10T01:22:42.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":1576336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mudit K. Jain, a director of the Issuer, and each of Messrs. Stack and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Such persons and entities disclaim beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":272391},"source":{"system":"sec-edgar","filing":"0001104659-18-031870","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031870/a4.xml","form_type":"4"}},{"id":3941061,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":3,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2018-05-10T01:22:42.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":1299847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mudit K. Jain, a director of the Issuer, and each of Messrs. Stack and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Such persons and entities disclaim beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":195465},"source":{"system":"sec-edgar","filing":"0001104659-18-031870","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031870/a4.xml","form_type":"4"}},{"id":3941060,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":3,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-05-10T01:22:42.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":2790760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mudit K. Jain, a director of the Issuer, and each of Messrs. Stack and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Such persons and entities disclaim beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":419663},"source":{"system":"sec-edgar","filing":"0001104659-18-031870","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031870/a4.xml","form_type":"4"}},{"id":3941059,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":3,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-05-10T01:22:42.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":3998154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the \"Certificate of Incorporation\")).  These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the \"Certificate of Incorporation\")).  These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the \"Certificate of Incorporation\")).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mudit K. Jain, a director of the Issuer, and each of Messrs. Stack and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Such persons and entities disclaim beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":741494},"source":{"system":"sec-edgar","filing":"0001104659-18-031870","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031870/a4.xml","form_type":"4"}},{"id":3941058,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":3,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:22:42.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":466494,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mudit K. Jain, a director of the Issuer, and each of Messrs. Stack and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Such persons and entities disclaim beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":2095507,"source":{"system":"sec-edgar","filing":"0001104659-18-031870","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031870/a4.xml","form_type":"4"}},{"id":3941057,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":3,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:22:42.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":272391,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mudit K. Jain, a director of the Issuer, and each of Messrs. Stack and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Such persons and entities disclaim beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":1629013,"source":{"system":"sec-edgar","filing":"0001104659-18-031870","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031870/a4.xml","form_type":"4"}},{"id":3941056,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":3,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:22:42.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":195465,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mudit K. Jain, a director of the Issuer, and each of Messrs. Stack and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Such persons and entities disclaim beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":1356622,"source":{"system":"sec-edgar","filing":"0001104659-18-031870","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031870/a4.xml","form_type":"4"}},{"id":3941055,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":3,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:22:42.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":419663,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mudit K. Jain, a director of the Issuer, and each of Messrs. Stack and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Such persons and entities disclaim beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":1161157,"source":{"system":"sec-edgar","filing":"0001104659-18-031870","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031870/a4.xml","form_type":"4"}},{"id":3941054,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":3,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:22:42.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":741494,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the \"Certificate of Incorporation\")).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mudit K. Jain, a director of the Issuer, and each of Messrs. Stack and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Such persons and entities disclaim beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":741494,"source":{"system":"sec-edgar","filing":"0001104659-18-031870","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031870/a4.xml","form_type":"4"}},{"id":4286990,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41683,"kind":"person","name":"Jain Mudit K.","position":3,"cik":"0001584404","reported_name":"Jain Mudit K.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":5,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-06-09T19:06:52.000Z","date":"2017-06-08","kind":"sale","acquired":false,"shares":78188,"price":37.7579,"value":2952214.6852,"ownership":{"direct":false,"nature":"By Synergy Life Science Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $37.65 to $38.54 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Messrs. Stack, Jain and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Each Reporting Person disclaims beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":2034524,"source":{"system":"sec-edgar","filing":"0001209191-17-039009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324130/000120919117039009/doc4.xml","form_type":"4"}},{"id":4286989,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":166873,"kind":"organization","name":"SYNERGY LIFE SCIENCE PARTNERS L P","position":1,"cik":"0001384771","reported_name":"SYNERGY LIFE SCIENCE PARTNERS L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166874,"kind":"organization","name":"Synergy Venture Partners, LLC","position":2,"cik":"0001584405","reported_name":"Synergy Venture Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41683,"kind":"person","name":"Jain Mudit K.","position":3,"cik":"0001584404","reported_name":"Jain Mudit K.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88099,"kind":"person","name":"Starling William N JR","position":4,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166875,"kind":"person","name":"Stack Richard S.","position":5,"cik":"0001584403","reported_name":"Stack Richard S.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-06-09T19:06:52.000Z","date":"2017-06-07","kind":"sale","acquired":false,"shares":271812,"price":37.3418,"value":10149949.3416,"ownership":{"direct":false,"nature":"By Synergy Life Science Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reflected is the weighted-average sale price for shares sold.  The range of sale prices for the transactions reported was $37.00 to $37.58 per share.  The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Synergy Venture Partners, LLC (\"SVP LLC\") serves as the sole General Partner of Synergy Life Science Partners, LP (\"Synergy\"). As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Messrs. Stack, Jain and Starling are Managers of SVP LLC and share voting and dispositive power over the shares held by Synergy. Each Reporting Person disclaims beneficial ownership of the shares held by Synergy except to the extent of his or its proportionate pecuniary interest therein."}],"balance_after":2112712,"source":{"system":"sec-edgar","filing":"0001209191-17-039009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324130/000120919117039009/doc4.xml","form_type":"4"}},{"id":4303802,"issuer":{"id":88098,"kind":"organization","name":"ASENSUS SURGICAL, INC.","symbol":"ASXC"},"owners":[{"id":88099,"kind":"person","name":"Starling William N JR","position":1,"cik":"0001324130","reported_name":"Starling William N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Award","published_at":"2017-05-26T16:21:29.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests 25% per quarter on each quarterly anniversary of the date of grant with the final vesting on the first anniversary of the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":0.48,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-035817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876378/000120919117035817/doc4.xml","form_type":"4"}}]}